Physician profile
Michael H Chu
NPI 1275784670
$4,954.74
in general payments reported to CMS, 2019-2025
39 companies · $947 in 2025
The $947 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $123 · 2021: $388 · 2022: $1,105 · 2023: $1,673 · 2024: $357 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,907 · Travel and Lodging: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,906.75 |
| Travel and Lodging | $1,070.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $1,070.57 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Janssen Pharmaceuticals, INC | $580.34 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $343.70 | 2020-2023 | Watchman Access System, Varithena Administration Pack |
| Abbvie INC. | $302.05 | 2022-2025 | Teflaro, Dalvance, Avycaz |
| Inari Medical, INC. | $284.32 | 2022 | |
| Integra Lifesciences Corporation | $226.23 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $222.99 | 2019-2024 | Grafix Pl, Collagenase Santyl |
| Bard Peripheral Vascular, INC. | $132.93 | 2022-2025 | Denali Vena Cava Filter, Pristine, Fluency Endovascular Stent Graft |
| Medtronic Vascular, INC. | $128.37 | 2019 | |
| Amgen INC. | $124.99 | 2025 | Repatha |
| Novo Nordisk INC | $114.13 | 2025 | Ozempic |
| Medtronic, INC. | $112.67 | 2021-2024 | Closurefast, Venaseal |
| Advanced Oxygen Therapy INC. | $109.63 | 2022-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Bioventus LLC | $99.93 | 2022-2023 | Theragenesis Bilayer Wound Matrix |
| Stryker Corporation | $94.23 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $93.86 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $93.76 | 2025 | Indigo System, Ruby Coil |
| Organogenesis INC. | $82.52 | 2022-2025 | Puraply Wound Matrix |
| Endologix LLC | $79.67 | 2021-2022 | |
| Cook Medical LLC | $63.37 | 2021-2025 | Zenith, Rosen |
| Lemaitre Vascular, INC. | $62.38 | 2023-2025 | Artegraft Vascular Graft |
| Kci USA, INC. | $53.10 | 2020 | |
| Cagent Vascular INC | $49.65 | 2025 | Serrantor |
| Terumo Medical Corporation | $38.45 | 2022 | |
| Philips North America LLC | $36.29 | 2022 | |
| Acera Surgical, INC. | $35.28 | 2024 | Restrata Wound Matrix |
| Becton, Dickinson and Company | $34.39 | 2025 | Venclose Maven Catheter |
| Kerecis Limited | $33.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Biotronik INC. | $29.36 | 2025 | Pulsar-18 T3 |
| Tactile Systems Technology INC | $28.99 | 2020-2025 | Flexitouch Plus, Nimbl |
| Mimedx Group, INC. | $27.45 | 2024 | |
| Ethicon US, LLC | $27.11 | 2025 | Vistaseal, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Davol INC. | $24.56 | 2025 | Ventralight St |
| Misonix INC | $21.85 | 2021 | |
| Depuy Synthes Sales INC. | $21.81 | 2022 | |
| Abbott Laboratories | $20.52 | 2024 | Esprit |
| Sirtex Medical INC | $18.22 | 2025 | Sir-Spheres Microspheres |
| Cordis US Corp. | $17.14 | 2023 | Mynxgrip |
| Derma Sciences, INC. | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.